首页> 外国专利> Method for inhibiting one or more activities of protein kinase, composed of 2 - 5 - One pirazolin - protein kinase inhibitor and Pharmaceutical composition containing same

Method for inhibiting one or more activities of protein kinase, composed of 2 - 5 - One pirazolin - protein kinase inhibitor and Pharmaceutical composition containing same

机译:抑制由2-5-1种吡唑啉-蛋白激酶抑制剂组成的蛋白激酶的一种或多种活性的方法以及含有该蛋白激酶的药物组合物

摘要

A method to inhibit one or more activities of kinase Protein comprising administering a compound of pirazolin - 2 - 5 - One represented by the formula (1) and physiologically acceptable Salts and Biologically Active Metabolites of the same, where r is selected from the group of a group Or replaced without replacing group consisting of: aliphatic, aromatic, a cycloalkyl Group (C3 - 6)A Group aralquilo Heterocyclic Group, an alkyl group, a cicloalquil (C3 - 6) and a group of heterociclil alkyl; r1 is Hydrogen or a-z; R2 is Hydrogen or replaced without replacing or selected from the group consisting of: Lower alkyl group, an Aromatic Group, a cycloalkyl Group (C3 - 6) Group, a Heterocyclic Group, an alkyl group aralquilo, a cicloalquil (C3 - 6)And a Group heterociclil alkyl; where a and Z are as described in the report.A compound of pirazolin - 2 - 5 - One represented by the formula (2) and physiologically acceptable salts thereof, wherein R is selected from the group consisting of substituted or non substituted indole: 1,2,3 - triazole, imidazole, benzimidazole, 1,2,4-triazole, also tetrahidroindol benzoindol azaindol -,,, Indazol, quinoline, pyridine, pyrazine, pyrimidine, benzene, pyrazole, pyrrole,Oxazole and thiazole; r1 is Hydrogen or - Z -, where a and Z are as described in the report. A Pharmaceutical composition comprising the compound described and a pharmaceutically acceptable diluent or vehicle.
机译:一种抑制激酶蛋白的一种或多种活性的方法,该方法包括给予pirazolin-2-5-式(1)表示的化合物及其生理上可接受的盐和生物活性代谢物,其中r选自取代或不取代的基团:脂肪族,芳香族,环烷基(C3-6),基团芳基杂环基,烷基,环氯基(C3-6)和杂环烷基。 r1是氢或a-z; R 2是氢或被取代而不被取代或选自:低级烷基,芳族基团,环烷基(C3-6)基团,杂环基团,烷基芳基,环氯基(C3-6)和a。杂环基烷基;吡唑啉-2--5-式(2)表示的化合物及其生理上可接受的盐,其中R选自取代或未取代的吲哚:1 ,2,3-三唑,咪唑,苯并咪唑,1,2,4-三唑,也有四氢吲哚,苯并吲哚,氮杂吲哚,吲哚唑,喹啉,吡啶,吡嗪,嘧啶,苯,吡唑,吡咯、,唑和噻唑; r1是氢或-Z-,其中a和Z如报告中所述。包含所述化合物和药学上可接受的稀释剂或媒介物的药物组合物。

著录项

  • 公开/公告号AR032279A1

    专利类型

  • 公开/公告日2003-11-05

    原文格式PDF

  • 申请/专利权人 ABBOTT GMBH & CO. KG;

    申请/专利号AR2000P103955

  • 发明设计人

    申请日2000-07-31

  • 分类号C07D403/06;C07D403/14;C07D401/14;C07D417/14;C07D405/14;C07D409/14;C07D413/14;C07D471/04;C07D231/20;C07D409/06;C07D401/06;A61K31/4155;A61K31/4152;

  • 国家 AR

  • 入库时间 2022-08-22 00:04:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号